Humacyte, Inc. Common Stock Shares Outstanding

Quick Answer

Humacyte, Inc. reported Common Stock Shares Outstanding of 193.00 million shares for the year ending 2025.

  • Humacyte, Inc. showed an increase of +48.4% in Common Stock Shares Outstanding from 2024 to 2025.
  • This data is from Humacyte, Inc.'s annual report (Form 10-K), filed with the SEC on March 27, 2026.
  • XBRL data for this metric is available from 2020 to 2025 (7 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
  • Over the full 7 years of available data (2020 to 2025), Humacyte, Inc.'s Common Stock Shares Outstanding has grown by 3,214.8%.
  • Historical annual values: Fiscal year 2025: 193.00 million shares | Fiscal year 2024: 130.03 million shares | Fiscal year 2023: 103.67 million shares | Fiscal year 2022: 103.23 million shares | Fiscal year 2021: 103.00 million shares | Fiscal year 2021: 103.00 million shares | Fiscal year 2020: 5.82 million shares.
  • Data sourced from SEC EDGAR public filings as of June 23, 2026.

Last verified: